Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination.

Authors: Datta, Pratik; Ukey, Rahul; Bruiners, Natalie; Honnen, William; Carayannopoulos, Mary O; Reichman, Charles; Choudhary, Alok; Onyuka, Alberta; Handler, Deborah; Guerrini, Valentina; Mishra, Pankaj K; Dewald, Hannah K; Lardizabal, Alfred; Lederer, Leeba; Leiser, Aliza L; Hussain, Sabiha; Jagpal, Sugeet K; Radbel, Jared; Bhowmick, Tanaya; Horton, Daniel B; Barrett, Emily S; Xie, Yingda L; Fitzgerald-Bocarsly, Patricia; Weiss, Stanley H; Woortman, Melissa; Parmar, Heta; Roy, Jason; Dominguez-Bello, Maria Gloria; Blaser, Martin J; Carson, Jeffrey L; Panettieri Jr, Reynold A; Libutti, Steven K; Raymond, Henry F; Pinter, Abraham; Gennaro, Maria Laura

Published In J Immunol Methods, (2021 Dec)

Abstract: Monitoring the burden and spread of infection with the new coronavirus SARS-CoV-2, whether within small communities or in large geographical settings, is of paramount importance for public health purposes. Serology, which detects the host antibody response to the infection, is the most appropriate tool for this task, since virus-derived markers are most reliably detected during the acute phase of infection. Here we show that our ELISA protocol, which is based on antibody binding to the Receptor Binding Domain (RBD) of the S1 subunit of the viral Spike protein expressed as a novel fusion protein, detects antibody responses to SARS-CoV-2 infection and vaccination. We also show that our ELISA is accurate and versatile. It compares favorably with commercial assays widely used in clinical practice to determine exposure to SARS-CoV-2. Moreover, our protocol accommodates use of various blood- and non-blood-derived biospecimens, such as breast milk, as well as dried blood obtained with microsampling cartridges that are appropriate for remote collection. As a result, our RBD-based ELISA protocols are well suited for seroepidemiology and other large-scale studies requiring parsimonious sample collection outside of healthcare settings.

PubMed ID: 34634317 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top